Ill see patients with underlying thyroid disease, underlying autoimmune disease, underlying neuroendocrine disease, Dr
Most clinical and research GHK-Cu protocols sit at 0.52 mg per day subcutaneously, and many patients do not inject every day - 23 injections per week is common for skin and maintenance goals
This means plasma concentrations fall by half every 6 days, enabling once-weekly subcutaneous dosing
Preeclampsia, placental rupture, spontaneous abortion, and miscarriage are all linked to elevated plasma homocysteine levels
If your syringe only shows whole units, draw to the nearest whole number and accept the minor variance
In laboratory research, its activity on skin's structural molecules has been observed at just 110 nanomolar a very low, nontoxic level , where GHK-Cu stimulated both the synthesis and breakdown of collagen and glycosaminoglycans.1 Signaling molecules like this work by fitting a lock, not by flooding the room